Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease in revenues. The company’s stock fell sharply during Tuesday’s after-hours trading session soon after the announcement.
The Canada-based medical marijuana company said its loss from continuing operations widened to C$1.86 billion in the fourth quarter from C$136.13 million in the third quarter. The deterioration in the bottom-line performance reflects a 5% decrease in revenues to C$72.1 million.
Shares of Aurora Cannabis closed Tuesday’s regular session higher in the New York Stock Exchange but decreased during the extended trading session. The stock, which has been on a losing streak for several months, has lost about 70% so far this year.
Most Popular
Earnings calendar for the week of May 17
Benchmark stock indexes pared their recent gains early this week amid elevated inflation concerns, but regained a part of the momentum later aided by recovery in tech stocks. The Dow
Alibaba (BABA): The good and the bad from the Q4 earnings report
Shares of Alibaba Group (NYSE: BABA) have dropped 10% since the beginning of the year. The company reported mixed results for the fourth quarter of 2021 a day ago, with
Walt Disney (DIS) is focused on reopening, to put up a better show this year
With some of its parks and resorts either closed or operating at reduced capacity even more than a year after the virus outbreak, The Walt Disney Company (NYSE: DIS) is
